글로벌 자동 세포 배양 시장 – 2031년까지의 산업 동향 및 예측

자동화된 세포 배양 시장 분석 및 통찰력

자동화된 세포 배양 시장은 생명공학, 제약 연구, 생물제약 제조의 발전에 힘입어 강력한 성장을 경험하고 있습니다. 이러한 자동화 시스템은 세포 배양 공정에서 생산성, 효율성, 재현성을 향상시키는 데 중요한 역할을 합니다. 시장 확장을 촉진하는 주요 요인에는 약물 발견에서 고처리량 스크리닝에 대한 수요 증가, 개인화된 의학에 대한 집중 증가, 효율적인 생물 생산 공정에 대한 필요성이 있습니다. 자동화된 세포 배양 시스템은 배지 보충, 세포 모니터링, 데이터 분석과 같은 작업을 자동화하여 노동 비용을 줄이고 인적 오류를 최소화합니다. 또한 인공 지능(AI) 및 머신 러닝(ML) 알고리즘과의 통합과 같은 기술적 발전은 세포 배양 조건을 더욱 최적화하고 실험 결과를 개선하고 있습니다.

글로벌 자동 세포 배양 시장 규모는 2023년에 129억 8천만 달러로 평가되었으며, 2031년까지 256억 7천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 8.9%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

시장 정의

자동화된 세포 배양은 실험실 환경에서 세포 배양을 성장시키고 유지하는 데 관련된 프로세스를 자동화하는 시스템과 기술을 말합니다. 이러한 시스템은 일반적으로 온도, 습도, CO2 수준과 같은 환경 조건을 제어하는 ​​자동화된 플랫폼과 세포 배양 용기의 자동화된 처리, 배지 변경, 세포 성장 및 생존력 모니터링을 포함합니다.             

자동화된 세포 배양 시장 동향

운전자

• 생물약품에 대한 수요 증가        

모노클로날 항체와 백신을 포함한 생물약품의 생산 증가는 견고하고 확장 가능한 세포 배양 시스템을 필요로 합니다. 자동화된 세포 배양 기술은 제조 공정을 간소화하고, 더 높은 제품 품질을 보장하며, 오염 위험을 최소화하는 데 핵심적입니다. 이러한 시스템은 생물약품 생산의 효율성과 재현성을 향상시켜 산업에서 없어서는 안 될 존재가 되었습니다. 다양한 질병을 치료하는 데 있어서 효과성과 특이성으로 인해 생물약품에 대한 수요가 계속 증가함에 따라 자동화된 세포 배양 시스템 시장이 상당히 확대될 것으로 예상됩니다.               

• 생명 과학 연구에 대한 투자 증가            

Substantial investments in life sciences research by governments, academic institutions, and private companies are driving the demand for advanced cell culture systems. Automated cell culture technologies are critical in enabling high-throughput screening and more efficient research workflows. These systems support a wide range of scientific discoveries by providing reliable and consistent cell cultures, which are essential for various research applications, including drug discovery and development. The continuous influx of funding into life sciences research underscores the importance of automated cell culture systems in advancing scientific knowledge and innovation.

Opportunities

• Expansion of Biotechnology and Pharmaceutical Industries   

The rapid growth of the biotechnology and pharmaceutical industries, fueled by the development of new drugs and therapies, is significantly increasing the need for automated cell culture systems. These industries rely on advanced cell culture technologies for various stages of drug discovery, development, and production. Automated systems offer the precision, scalability, and efficiency required to meet the high demands of these processes. As biotechnology and pharmaceutical companies continue to expand and innovate, the adoption of automated cell culture systems is expected to rise, creating opportunities for market growth.              

• Technological Advancements in Cell Culture Systems   

Continuous innovations in automated cell culture technologies, including the integration of artificial intelligence (AI) and machine learning, are revolutionizing the field. These advancements enhance the efficiency, accuracy, and scalability of cell culture processes, making them more accessible and effective for various applications. AI and machine learning algorithms optimize cell growth conditions, predict potential issues, and streamline operations, leading to more consistent and reliable outcomes. The ongoing technological advancements are driving the widespread adoption of automated cell culture systems in both research and industrial settings, contributing to market expansion.

Restraints/Challenges

• High Initial Costs for Cell Culture Systems   

The significant capital investment required for acquiring and installing automated cell culture systems poses a major barrier, particularly for smaller laboratories and research institutions. The high costs associated with purchasing the equipment, as well as the expenses related to maintenance and training, can limit market adoption. Smaller entities may struggle to justify the upfront costs despite the long-term benefits, potentially slowing down the widespread implementation of these advanced systems, and creating challenges for the market.    

• Technical Complexity of Cell Culture Systems        

The complexity of automated cell culture systems, including the need for specialized skills and expertise for their operation and maintenance, can hinder their widespread adoption. Laboratories may face significant challenges in integrating these sophisticated systems into their existing workflows. The technical demands require substantial training and adaptation, which can be daunting for some users. Overcoming these technical hurdles through user-friendly designs and comprehensive training programs is essential to facilitate broader acceptance and utilization of automated cell culture technologies.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2024, SINFONIA TECHNOLOGY CO., LTD. announced the delivery of two units of its CellQualia Intelligent Cell Processing (ICP) System to Keio University. These systems were delivered in March and completed their Performance Qualification in April of the same year. The devices are set to support the stable production and supply of high-quality cell medicines, crucial for advancing regenerative medicine, a promising next-generation medical treatment
• In October 2023, Molecular Devices, LLC., a prominent provider of high-performance solutions in life sciences and an operating entity within Danaher Corporation's (NYSE: DHR) life sciences segment, introduced the patent-pending CellXpress.ai Automated Cell Culture System. This innovative solution integrates an incubator, liquid handler, and imager, enhanced with machine-learning capabilities

Automated Cell Cultures Market Scope

The market is segmented on the basis of products, type, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Product

• Consumables
• Instruments

 Type

• Infinite Cell Line Cultures
• Finite Cell Line Cultures

 Application

• Drug Development
• Stem Cell Research
• Regenerative Medicine
• Cancer Research
• Vaccines
• Other

End User

• Biotech Companies
• Research Organizations
• Academic Research Institutes
• Other

Automated Cell Cultures Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, source, products, type, application, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to substantial investments in life sciences. This region benefits from a robust infrastructure for research and development, with significant funding directed towards lab consumables and advanced technologies. Pharmaceutical and biotechnological industries in North America are heavily investing in automated cell culture systems to enhance their research capabilities and streamline production processes.        

Asia-Pacific is expected to witness significant growth during the forecast period due to increasing productivity and investments in life sciences. Countries in this region, such as China, India, and Japan, are making significant strides in biotechnology and pharmaceutical research. Government initiatives and favorable policies aimed at boosting healthcare infrastructure and research capabilities are contributing to the market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Automated Cell Cultures Market Share Analysis

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• Sartorius AG(독일)
• 다나허(미국)
• 론자(스위스)
• 넥셀롬 바이오사이언스 LLC (미국)
• HiMedia Laboratories(인도)
• 셀 컬쳐 컴퍼니, LLC (미국)
• 고급 기기(미국)
• 시부야 주식회사(일본)
• 나노엔텍(한국)
• 후지필름 홀딩스 아메리카 코퍼레이션(미국)
• 히타치 주식회사(미국)
• 가와사키 중공업 주식회사(일본)
• Sphere Fluidics Limited(영국)
• Thrive Bioscience (미국)
• 에펜도르프 AG(독일)
• CellGenix GmbH(독일)
• 케모메텍(덴마크)
• PromoCell GmbH(독일)
• Thermo Fisher Scientific(미국)
• BioSpherix, Ltd. (미국)
• 머크 KGaA(독일)
• Tecan Trading AG(스위스)
• 해밀턴 회사(미국)
• BD(미국)
• Benchmark Scientific, Inc. (미국)
• Biotron Healthcare(인도)
• RWD 생명과학 주식회사(미국)
• 코닝 주식회사(미국)
• 불독-바이오(미국)
• Sphere Fluidics Limited(영국)

SKU-13174